Cargando…
Qualitative and Quantitative Image-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer
Experimental targeted treatments for neoadjuvant chemotherapy for triple-negative breast cancer are currently underway, and a current challenge is predicting which patients will respond to these therapies. In this study, we use data from dynamic contrast-enhanced MRI (DCE-MRI) images to predict whet...
Autores principales: | Golden, Daniel I., Lipson, Jafi A., Telli, Melinda L., Ford, James M., Rubin, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Informatics Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083372/ https://www.ncbi.nlm.nih.gov/pubmed/24303300 |
Ejemplares similares
-
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017) -
Antimicrobial exposure is associated with decreased survival in triple-negative breast cancer
por: Ransohoff, Julia D., et al.
Publicado: (2023) -
Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
por: Patwa, Aalok, et al.
Publicado: (2021) -
PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018) -
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)